These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Linsitinib (OSI-906) antagonizes ATP-binding cassette subfamily G member 2 and subfamily C member 10-mediated drug resistance. Zhang H; Kathawala RJ; Wang YJ; Zhang YK; Patel A; Shukla S; Robey RW; Talele TT; Ashby CR; Ambudkar SV; Bates SE; Fu LW; Chen ZS Int J Biochem Cell Biol; 2014 Jun; 51():111-9. PubMed ID: 24726739 [TBL] [Abstract][Full Text] [Related]
4. The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors. Zhang H; Patel A; Wang YJ; Zhang YK; Kathawala RJ; Qiu LH; Patel BA; Huang LH; Shukla S; Yang DH; Ambudkar SV; Fu LW; Chen ZS Mol Cancer Ther; 2017 Jun; 16(6):1021-1030. PubMed ID: 28265007 [TBL] [Abstract][Full Text] [Related]
5. Imatinib and nilotinib reverse multidrug resistance in cancer cells by inhibiting the efflux activity of the MRP7 (ABCC10). Shen T; Kuang YH; Ashby CR; Lei Y; Chen A; Zhou Y; Chen X; Tiwari AK; Hopper-Borge E; Ouyang J; Chen ZS PLoS One; 2009 Oct; 4(10):e7520. PubMed ID: 19841739 [TBL] [Abstract][Full Text] [Related]
6. bba, a synthetic derivative of 23-hydroxybutulinic acid, reverses multidrug resistance by inhibiting the efflux activity of MRP7 (ABCC10). Chen JJ; Patel A; Sodani K; Xiao ZJ; Tiwari AK; Zhang DM; Li YJ; Yang DH; Ye WC; Chen SD; Chen ZS PLoS One; 2013; 8(9):e74573. PubMed ID: 24069321 [TBL] [Abstract][Full Text] [Related]
7. Tandutinib (MLN518) reverses multidrug resistance by inhibiting the efflux activity of the multidrug resistance protein 7 (ABCC10). Deng W; Dai CL; Chen JJ; Kathawala RJ; Sun YL; Chen HF; Fu LW; Chen ZS Oncol Rep; 2013 Jun; 29(6):2479-85. PubMed ID: 23525656 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of anticancer drug sensitivity in multidrug resistance cells overexpressing ATP-binding cassette (ABC) transporter ABCC10 by CP55, a synthetic derivative of 5-cyano-6-phenylpyrimidin. Wang JQ; Wang B; Ma LY; Shi Z; Liu HM; Liu Z; Chen ZS Exp Cell Res; 2021 Aug; 405(2):112728. PubMed ID: 34246653 [TBL] [Abstract][Full Text] [Related]
9. Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. Kathawala RJ; Chen JJ; Zhang YK; Wang YJ; Patel A; Wang DS; Talele TT; Ashby CR; Chen ZS Int J Oncol; 2014 May; 44(5):1634-42. PubMed ID: 24626598 [TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 10 (ABCC10) are not primary resistance factors for cabazitaxel. Kathawala RJ; Wang YJ; Shukla S; Zhang YK; Alqahtani S; Kaddoumi A; Ambudkar SV; Ashby CR; Chen ZS Chin J Cancer; 2015 Mar; 34(3):115-20. PubMed ID: 25962593 [TBL] [Abstract][Full Text] [Related]
12. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547 [TBL] [Abstract][Full Text] [Related]
13. The role of ABCC10/MRP7 in anti-cancer drug resistance and beyond. Chen DQ; Xie Y; Cao LQ; Fleishman JS; Chen Y; Wu T; Yang DH Drug Resist Updat; 2024 Mar; 73():101062. PubMed ID: 38330827 [TBL] [Abstract][Full Text] [Related]
14. Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice. Hopper-Borge EA; Churchill T; Paulose C; Nicolas E; Jacobs JD; Ngo O; Kuang Y; Grinberg A; Westphal H; Chen ZS; Klein-Szanto AJ; Belinsky MG; Kruh GD Cancer Res; 2011 May; 71(10):3649-57. PubMed ID: 21576088 [TBL] [Abstract][Full Text] [Related]
17. ABCC10/MRP7 is associated with vinorelbine resistance in non-small cell lung cancer. Bessho Y; Oguri T; Ozasa H; Uemura T; Sakamoto H; Miyazaki M; Maeno K; Sato S; Ueda R Oncol Rep; 2009 Jan; 21(1):263-8. PubMed ID: 19082471 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of pentacyclic strychnos alkaloids as selective modulators of the ABCC10 (MRP7) efflux pump. Teijaro CN; Munagala S; Zhao S; Sirasani G; Kokkonda P; Malofeeva EV; Hopper-Borge E; Andrade RB J Med Chem; 2014 Dec; 57(24):10383-90. PubMed ID: 25419978 [TBL] [Abstract][Full Text] [Related]
19. MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer. Oguri T; Ozasa H; Uemura T; Bessho Y; Miyazaki M; Maeno K; Maeda H; Sato S; Ueda R Mol Cancer Ther; 2008 May; 7(5):1150-5. PubMed ID: 18445659 [TBL] [Abstract][Full Text] [Related]
20. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells. Gupta P; Zhang YK; Zhang XY; Wang YJ; Lu KW; Hall T; Peng R; Yang DH; Xie N; Chen ZS Cell Physiol Biochem; 2018; 45(4):1515-1528. PubMed ID: 29486476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]